Lyell Immunopharma, Inc.
CUSIP 55083R104
Lyell Immunopharma, Inc. has 1 institutional holders in Filings Flow’s 13F database, together reporting 692.0K shares worth $14M as of Q1 2026. The largest reported holders are Decheng Capital LLC, Mwg Management Ltd., and Orland Properties Ltd.
Institutional Holders
1
Q1 2026
Reported Value
$14M
Ticker
unmapped
private placement or foreign
Quarters Tracked
20
Ownership Trend
Institutional holders
Total reported value
Holders
··Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Decheng Capital LLC$661M AUM | 2.10% | $14M | 692.0K | Q1 2026 |
| MWG Management Ltd.$81M AUM | 17.17% | $9M | 1.01M | Q2 2025OLDER |
| Orland Properties Ltd$267M AUM | 2.83% | $7M | 754.7K | Q2 2025OLDER |
| TAKEDA PHARMACEUTICAL CO LTD$16M AUM | 5.45% | $891,365 | 54.9K | Q3 2025OLDER |
| JOHNSON & JOHNSON$652M AUM | 0.11% | $368,015 | 41.2K | Q2 2025OLDER |
| IFP Advisors, Inc$4.8B AUM | 0.00% | $28 | 63 | Q2 2025OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.